Skip to content

Analysis of Stannous Fluoride in GCF and Subgingival Plaque

A Pilot Study to Evaluate Stannous Fluoride in GCF and Subgingival Plaque

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03296657
Enrollment
20
Registered
2017-09-28
Start date
2017-08-23
Completion date
2017-09-22
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GCF, Subgingival Plaque

Brief summary

The amount of stannous fluoride in GCF and subgingival plaque samples will be analyzed.

Detailed description

This is pilot study involving approximately 20 subjects with at least 20 dental pockets between 2- 4mm with bleeding for sampling. Subjects will have up to 10 sites identified as sampling sites that will have supragingival plaque, subgingival plaque, and gingival crevicular fluid (GCF) collected at Baseline, 30 minutes, 24 hours, and Week 2.

Interventions

DRUGstannous fluoride

subjects will brush with paste twice daily for 2 weeks

Sponsors

Procter and Gamble
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

subject will brush twice a day for 2 weeks with stannous fluoride paste for at least 1 minute

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Provide written informed consent to participate in the study; * Be 18 years of age or older; * Agree not to participate in any other oral/dental product studies during the course of this study; * Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed; * Agree to use the acclimation products and to refrain from using any other oral care products (including floss and mouth rinse) between the Acclimation and Baseline Visit; * Agree to use the treatment products and refrain from any form of non-specified oral hygiene during the treatment periods (after the Baseline Visit), including but not limited to the use of products such as floss, mouth rinse, or whitening products; * Agree to return for all scheduled visits and follow study procedures; * Must have at least 16 natural teeth; * Be in good general health, as determined by the Investigator/designee based on a review of the health history/update for participation in the study; * Agree to refrain from all oral hygiene after 11 p.m. the night prior to each visit; * Agree to refrain from eating, chewing gum, drinking and using tobacco for 4 hours prior to each visit; * Have minimum 20 sampling sites with bleeding and pocket depth ≥2mm but not deeper than 4mm.

Exclusion criteria

* Having a dental prophylaxis within 2 weeks of Acclimation visit; * Having rampant caries, open or untreated caries, or advanced periodontitis requiring prompt treatment; * A medical condition requiring an antibiotic prophylaxis prior to dental visits; * A history of hypersensitivity to oral care products containing stannous fluoride; or * Have any condition or disease, as determined by the Investigator/Designee based on a review of the medical history, which could be expected to interfere with examination procedures or with the subject's safe completion of the study.

Design outcomes

Primary

MeasureTime frameDescription
Amount of tin in GCF samplemean difference from 30 minutes to baselineper GCF sample amount of stannous level in ng/uL will be measured

Secondary

MeasureTime frameDescription
Amount of tin in GCF and Subgingival Plaquechange from visit (change from 24 hours to baseline, change Week 2 to baseline)stannous level in subgingival plaque will be measured as concentration in ng, per GCF sample amount of stannous level in ng/uL

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026